Read + Share
Lebwohl M, Warren RB, Sofen H, Imafuku S, et al. Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the
phase 3 poetyk trials. Br J Dermatol 2024 Jan 16:ljae014. doi: 10.1093.
PMID: 38226713
|
 |
|
Lebwohl M, Warren RB, Sofen H, Imafuku S, et al. Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the
phase 3 poetyk trials. Br J Dermatol 2024 Jan 16:ljae014. doi: 10.1093.
PMID: 38226713
|
|
|
|